Ra Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Ra Pharmaceuticals Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Ra Pharmaceuticals Inc Strategy Report

  • Understand Ra Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Ra Pharmaceuticals Inc: Overview

Select Item

Ra Pharmaceuticals Inc (Ra Pharmaceuticals), a subsidiary of UCB SA is a clinical stage biopharmaceutical company that develops therapeutics for patients with rare diseases based on its Extreme Diversity technology platform. It has pipeline products in pre-clinical, Phase I and Phase II trials for CNS diseases, autoimmune and renal disorders. The company’s lead product candidate, Zilucoplan, is a self-administered subcutaneous (SC) injection for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and generalized myasthenia gravis (gMG). The company has collaboration with other companies to carry out the pre-clinical programs for glomerulonephritis (C3GN), and dense deposit disease (DDD). Ra Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Ra Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Ra Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 87 CambridgePark Drive, Massachusetts, 02140
Website www.rapharma.com
Telephone 1 617 4014060
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Ra Pharmaceuticals Inc premium industry data and analytics

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Ra Pharmaceuticals Inc’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Ra Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

18+

Clinical Trials

Determine Ra Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

10+

Pipeline Drugs

Identify which of Ra Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline
Zilucoplan
Oral Macrocyclic Peptide
Understand Ra Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Ra Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more
Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Ra Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Ra Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward